Find similar content

Source channel @githubtrending · Post #14969 · Jul 17

#cplusplus#artificial_intelligence#cloud#cloud_native#cncf#container#docker#edge_computing#ewasm#hacktoberfest#hacktoberfest2023#kubernetes#rust_lang#serverless#wasm#webassembly WasmEdge is a fast, lightweight, and secure WebAssembly runtime that lets you run programs safely on your devices, servers, or the cloud. It supports many programming languages like C++, Rust, and JavaScript, and can run AI models, microservices, and smart contracts efficiently. WasmEdge offers strong security by isolating programs, making it great for extending software safely. It works well on edge devices, smart devices, and cloud environments, and supports easy integration with tools like Kubernetes and Docker. Using WasmEdge helps you run powerful applications faster, safer, and more flexibly on various platforms[1][2][3][4][5]. https://github.com/WasmEdge/WasmEdge

Hashtags

#cplusplus #artificial_intelligence #cloud #cloud_native #cncf #container #docker #edge_computing #ewasm #hacktoberfest #hacktoberfest2023 #kubernetes #rust_lang #serverless #wasm #webassembly

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选

Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

Find similar View

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Hashtags

#hongkong #pharmaceuticals #biotech #innovation #stockmarket #healthcare #drugdevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

Find similar View

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment

Hashtags

#biotech #funding #cancer #immunedisorders #california #clinicalstage #therapies #investment #healthcare #innovation #pepromenebio #pharmaceuticals #medicalresearch #drugdevelopment